Viewing Study NCT00281827


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT00281827
Status: TERMINATED
Last Update Posted: 2017-12-28
First Post: 2006-01-24
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-05
Start Date Type: None
Primary Completion Date: 2008-03
Primary Completion Date Type: ACTUAL
Completion Date: 2008-07
Completion Date Type: ACTUAL
First Submit Date: 2006-01-24
First Submit QC Date: None
Study First Post Date: 2006-01-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-06-23
Results First Submit QC Date: None
Results First Post Date: 2009-12-03
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-12-03
Last Update Post Date: 2017-12-28
Last Update Post Date Type: ACTUAL